AI Verdict
ZTS has stronger fundamentals based on our AI analysis.
HCA vs ZTS Fundamental Comparison
| Metric | HCA | ZTS |
|---|---|---|
| Revenue | $75.6B | $9.5B |
| Net Income | $6.8B | $2.7B |
| Net Margin | 9.0% | 28.2% |
| ROE | N/A | 80.2% |
| ROA | 11.2% | 17.3% |
| Current Ratio | 0.97x | 3.03x |
| Debt/Equity | N/A | 2.71x |
| EPS | $28.33 | $6.02 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
HCA vs ZTS: Frequently Asked Questions
Is HCA or ZTS a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), ZTS has stronger fundamentals. HCA is rated BUY (75% confidence) while ZTS is rated BUY (78% confidence). This is not investment advice.
How does HCA compare to ZTS fundamentally?
HCA Healthcare, Inc. has ROE of N/A vs Zoetis Inc.'s 80.2%. Net margins are 9.0% vs 28.2% respectively.
Which stock pays higher dividends, HCA or ZTS?
HCA has a dividend yield of N/A or no dividend while ZTS has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in HCA or ZTS for long term?
For long-term investing, consider that HCA has BUY rating with 75% confidence, while ZTS has BUY rating with 78% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about HCA vs ZTS?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For HCA vs ZTS, the AI consensus favors ZTS based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.